Does hepatitis B seroconversion affect survival outcome in patients with hepatitis B related hepatocellular carcinoma?

BACKGROUND: Little is known about whether hepatitis B surface antigen (HBsAg) seroconversion (SC) contributes to any survival benefits for patients with hepatocellular carcinoma (HCC). METHODS: All patients with hepatitis B-related HCC and HBsAg seroclearance between 1989 and 2013 were identified. C...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transl Gastroenterol Hepatol
Hauptverfasser: Yip, Vincent S.K., Cheung, Tan To, Poon, Ronnie T.P., Yau, Thomas, Fung, James, Dai, Wing Chiu, Chan, Albert C.Y., Chok, Siu Ho, Chan, See Ching, Lo, Chung Mau
Format: Artigo
Sprache:Inglês
Veröffentlicht: AME Publishing Company 2016
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5244806/
https://ncbi.nlm.nih.gov/pubmed/28138618
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tgh.2016.05.11
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge